Gen9
私人持有Gen9 由麻省理工学院Joseph Jacobson2009年创建，它已经开发的基因合成技术，可实现比先前方法更低成本、更高精度，以高通量、自动化方式合成DNA结构。它的BioFab平台能够合成数万成千上万的基因片段，同时所需的实验室空间仅需几平方英尺。

Gen9 is building on advances in synthetic biology to power a scalable fabrication capability that will significantly increase the world’s capacity to produce DNA content. The privately held company’s next-generation gene synthesis technology allows for the high-throughput, automated production of DNA constructs at lower cost and higher accuracy than previous methods on the market. Founded by world leaders in synthetic biology, Gen9 aims to ensure the constructive application of synthetic biology in industries ranging from enzyme and chemical production to pharmaceuticals and biofuels. Gen9 is based in Cambridge, Mass.